These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3380318)

  • 21. Chlorpropamide alters AVP-receptor binding of rat renal tubular membranes.
    Muta T; Takasugi M; Kuroiwa A
    Eur J Pharmacol; 1989 Jan; 159(2):191-4. PubMed ID: 2707308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Through the central V2, not V1 receptors influencing the endogenous opiate peptide system, arginine vasopressin, not oxytocin in the hypothalamic paraventricular nucleus involves in the antinociception in the rat.
    Yang J; Chen JM; Song CY; Liu WY; Wang G; Wang CH; Lin BC
    Brain Res; 2006 Jan; 1069(1):127-38. PubMed ID: 16409991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal regulation of rat testicular arginine vasopressin receptors.
    Kasson BG; Tuchel TL
    Endocrinology; 1989 Jun; 124(6):2777-84. PubMed ID: 2498062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of angiotensin and vasopressin V(1) receptors on water and sodium intake induced by injection of vasopressin into lateral septal area.
    Mima EG; Andrade RR; Camargo LA; Saad WA
    Regul Pept; 2004 May; 118(3):159-64. PubMed ID: 15003832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal tubular vasopressin receptors downregulated by dehydration.
    Steiner M; Phillips MI
    Am J Physiol; 1988 Mar; 254(3 Pt 1):C404-10. PubMed ID: 2831732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells.
    Okada K; Ishikawa S; Saito T
    Biochem Biophys Res Commun; 1991 Jul; 178(2):707-12. PubMed ID: 1650196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arginine vasopressin stimulates atrial natriuretic peptide gene expression and secretion from rat diencephalic neurons.
    Levin ER; Hu RM; Rossi M; Pickart M
    Endocrinology; 1992 Sep; 131(3):1417-23. PubMed ID: 1380442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vasopressin receptor system in the neonatal pituitary gland: evidence for reduced binding capacity and signal transmission.
    Koch B; Lutz-Bucher B
    Neuroendocrinology; 1990 May; 51(5):592-8. PubMed ID: 2162016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney.
    Marchingo AJ; Abrahams JM; Woodcock EA; Smith AI; Mendelsohn FA; Johnston CI
    Endocrinology; 1988 Apr; 122(4):1328-36. PubMed ID: 2964362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal and central vasopressin receptors: immunocytochemical localization.
    Fahrenholz F; Jurzak M; Gerstberger R; Haase W
    Ann N Y Acad Sci; 1993 Jul; 689():194-206. PubMed ID: 8373014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional distribution of putative vasopressin receptors in rat brain and pituitary by quantitative autoradiography.
    Brinton RE; Gee KW; Wamsley JK; Davis TP; Yamamura HI
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7248-52. PubMed ID: 6095279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary binding of vasopressin is altered by experimental manipulations of the hypothalamo-pituitary-adrenocortical axis in normal as well as homozygous (di/di) Brattleboro rats.
    Antoni FA; Holmes MC; Kiss JZ
    Endocrinology; 1985 Oct; 117(4):1293-9. PubMed ID: 3161722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Becker EL
    J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity of vasopressin binding to the posterior pituitary gland in the rat. An autoradiographic study.
    Dashwood MR; Robinson IC
    Neuroendocrinology; 1988 Aug; 48(2):180-7. PubMed ID: 2851751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroosmotic activities of arginine-vasopressins modified either in positions 1, 2 and 4 or at N-terminal extensions.
    Bakos P; Shakhmatova EI; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1992 Aug; 11(4):359-76. PubMed ID: 1426981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of vasopressin receptors of rat urinary bladder and spleen.
    Thibonnier M; Snajdar RM; Rapp JP
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H115-20. PubMed ID: 3014903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of ANG II and AVP receptors in isolated hepatocytes of pregnant rats.
    Massicotte G; Coderre L; Chiasson JL; Thibault G; Schiffrin EL; St-Louis J
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E597-605. PubMed ID: 2333959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of arginine vasopressin receptors in the rat testis.
    Meidan R; Hsueh AJ
    Endocrinology; 1985 Jan; 116(1):416-23. PubMed ID: 2981073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of V(1) receptors in renal resistance vessels of rats developing genetic hypertension.
    Vågnes O; Feng JJ; Iversen BM; Arendshorst WJ
    Am J Physiol Renal Physiol; 2000 Jun; 278(6):F940-8. PubMed ID: 10836981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.